PharmaEngine, Inc. (TPEX:4162)

Taiwan · Delayed Price · Currency is TWD

57.00

+0.10 (0.18%)

At close: Mar 24, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
New Medicine Development	911.42M	2.52B	767.67M	654.38M	654.84M
New Medicine Development Growth	-63.88%	228.70%	17.31%	-0.07%	-37.99%
Total	911.42M	2.52B	767.67M	654.38M	654.84M
Total Growth	-63.88%	228.70%	17.31%	-0.07%	-37.99%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	2.52B	767.67M	654.38M	654.84M
Taiwan Growth	228.70%	17.31%	-0.07%	-37.99%
Total	2.52B	767.67M	654.38M	654.84M
Total Growth	228.70%	17.31%	-0.07%	-37.99%

Source: S&P Global Market Intelligence.